Literature DB >> 11873781

Adverse events after imatinib mesylate therapy.

Catherine Burton, Anthony Azzi, Ian Kerridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11873781

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.

Authors:  Katsuya Ikuta; Yoshihiro Torimoto; Junko Jimbo; Junki Inamura; Motohiro Shindo; Kazuya Sato; Yoshihiko Tokusashi; Naoyuki Miyokawa; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

2.  Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.

Authors:  Hawk Kim; Heung-Moon Chang; Min-Hee Ryu; Tae-Won Kim; Hee-Jung Sohn; So-Eun Kim; Hye-Jin Kang; Sarah Park; Jung-Shin Lee; Yoon-Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

3.  Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.

Authors:  Ping Dong; Rong Tian; Lin Li; Minggang Su
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.